Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody.
Arthritis Rheum. 2004 Jun 15;51(3):447-50. doi: 10.1002/art.20407.
Arthritis Rheum. 2004.
PMID: 15188332
Clinical Trial.